Ethical Implications of Nutrition Therapy at the End of Life

被引:3
作者
Bower K.L. [1 ,5 ]
Shilling D.M. [2 ]
Bonnes S.L. [2 ]
Shah A. [3 ]
Lawson C.M. [4 ]
Collier B.R. [1 ]
Whitehead P.B. [5 ]
机构
[1] Carilion Clinic, Department of Surgery, Virginia Tech Carilion School of Medicine, 1906 Belleview Ave., Roanoke, 24014, VA
[2] Mayo Clinic, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN
[3] Cooper University Health Care, Cooper Medical School of Rowan University Digestive Health Institute, Camden, NJ
[4] Division of Trauma and Critical Care Surgery, Univeristy of Tennessee, Knoxville, TN
[5] Carilion Clinic Palliative Medicine, Virginia Tech Carilion School of Medicine, 1906 Belleview Ave, Roanoke, 24014, VA
关键词
Artificial nutrition; End of life; Enteral nutrition; Ethics; Medically administered nutrition; Parenteral nutrition; Shared decision-making;
D O I
10.1007/s11894-023-00862-z
中图分类号
学科分类号
摘要
Purpose of Review: Provide an evidence-based resource to inform ethically sound recommendations regarding end of life nutrition therapy. Recent Findings: • Some patients with a reasonable performance status can temporarily benefit from medically administered nutrition and hydration(MANH) at the end of life. • MANH is contraindicated in advanced dementia. • MANH eventually becomes nonbeneficial or harmful in terms of survival, function, and comfort for all patients at end of life. • Shared decision-making is a practice based on relational autonomy, and the ethical gold standard in end of life decisions. Summary: A treatment should be offered if there is expectation of benefit, but clinicians are not obligated to offer non-beneficial treatments. A decision to proceed or not should be based on the patient’s values and preferences, a discussion of all potential outcomes, prognosis for given outcomes taking into consideration disease trajectory and functional status, and physician guidance provided in the form of a recommendation. © 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码:69 / 74
页数:5
相关论文
共 60 条
[1]  
Konsman J.P., Parnet P., Dantzer R., Cytokine-induced sickness behaviour: mechanisms and implications, Trends Neurosci, 25, 3, pp. 154-159, (2002)
[2]  
Francesconi W., Sanchez-Alavez M., Berton F., Alboni S., Benatti C., Mori S., Et al., The Proinflammatory Cytokine Interleukin 18 Regulates Feeding by Acting on the Bed Nucleus of the Stria Terminalis, J Neurosci, 36, 18, pp. 5170-5180, (2016)
[3]  
Alboni S., Cervia D., Ross B., Montanari C., Gonzalez A.S., Sanchez-Alavez M., Et al., Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain, J Neuroimmunol, 214, 1-2, pp. 43-54, (2009)
[4]  
Alboni S., Cervia D., Sugama S., Conti B., Interleukin 18 in the CNS, J Neuroinflammation, 7, 1, (2010)
[5]  
Alboni S., Montanari C., Benatti C., Blom J.M.C., Simone M.L., Brunello N., Et al., Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain, Brain Behav Immun, 25, 3, pp. 483-493, (2011)
[6]  
Schutte K., Middelberg-Bisping K., Schulz C., Nutrition and gastroenterological support in end of life care, Best Practice and Research: Clinical Gastroenterology: Bailliere Tindall Ltd, (2020)
[7]  
Arends J., Bachmann P., Baracos V., Barthelemy N., Bertz H., Bozzetti F., Et al., ESPEN guidelines on nutrition in cancer patients, Clin Nutr: Churchill Livingstone, pp. 11-48, (2017)
[8]  
Heuberger R.A., Medically administered nutrition and hydration at the end of life, J Nutr Elderly, pp. 347-385, (2010)
[9]  
Beauchamp T., Childress J., Principles of biomedical ethics, (2019)
[10]  
Varkey B., Principles of Clinical Ethics and Their Application to Practice, Med Princ Pract, pp. 17-28, (2021)